BISMUSOL- bismuth subsalicylate suspension 
IBA, INC.

Disclaimer: This drug has not been found by FDA to be safe and effective, and this labeling has not been approved by FDA. For further information about unapproved drugs, click here.

----------

BISMUSOL

Anti-Diarrheal Liquid Palatable Oral Suspension

FOR ANIMAL USE ONLY
KEEP OUT OF REACH OF CHILDREN

INDICATIONS:

A palatable oral suspension for use as an aid in controlling simple diarrhea in cattle, horses, dogs and cats.

CAUTION:

This product contains salicylate; do not administer with other products containing salicylate, such as aspirin. Do not administer to pregnant animals unless prescribed by a licensed veterinarian.

DOSAGE AND ADMINISTRATION:

Administer orally.
Dogs and Cats - 1 to 3 tablespoonfuls every 1-3 hours.
Calves and Foals - 3 to 4 ounces every 2-3 hours.
Horses and Cattle - 6 to 10 ounces every 2-3 hours.

image of eye clock

ACTIVE INGREDIENT:

Bismuth Subsalicylate ..............1.75% w/w

In a palatable aqueous suspension.
Flavoring and coloring added.

INACTIVE INGREDIENTS:

Water, Xanthan Gum, Magnesium Salicylate, Methyl Salicylate, Sodium Saccharin, Hydrochloric Acid, Methylparaben, Propylparaben, and FD&C Red #40.

WARNING:

If diarrhea persists after using this product for 2 days, consult a veterinarian.

STORAGE:

Store at controlled room temperature between 15°-30°C (59°-86°F). Keep container tightly closed when not in use.
SHAKE WELL BEFORE USING
FOR ORAL USE ONLY
KEEP FROM FREEZING

Net Contents:

1 Gallon (3.785 L)

Manufactured for:
      IBA Inc.
Animal Health Division
27 Providence Road
Millbury, MA 01527

IBA STOCK # 524250

09FP7

1 Gallon (3.785 L) rev. 04-15

image of LBIBMS120_r0415

BISMUSOL 
bismuth subsalicylate suspension
Product Information
Product TypeOTC ANIMAL DRUGItem Code (Source)NDC:29983-0221
Route of AdministrationORAL
Active Ingredient/Active Moiety
Ingredient NameBasis of StrengthStrength
BISMUTH SUBSALICYLATE (UNII: 62TEY51RR1) (SALICYLIC ACID - UNII:O414PZ4LPZ) BISMUTH SUBSALICYLATE17.4 g  in 1 L
Packaging
#Item CodePackage DescriptionMarketing Start DateMarketing End Date
1NDC:29983-0221-14 in 1 CASE
13.785 L in 1 JUG
Marketing Information
Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
unapproved drug other01/23/201806/29/2023
Labeler - IBA, INC. (019494160)
Establishment
NameAddressID/FEIBusiness Operations
First Priority Incorporated179925722manufacture, label, api manufacture

Revised: 6/2023
 
IBA, INC.